Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Increasing interest surrounds potential neuroprotective or neurotrophic actions of antidepressants. While growing evidence points to important early clinical and neuropsychological effects of antidepressants, the time-course of any effect on neuronal integrity is unclear. This study used magnetic resonance spectroscopy to assess effects of short-term treatment with escitalopram on N-acetyl-aspartate (NAA), a marker of neuronal integrity. Thirty-nine participants with major depression were randomly assigned to receive either 10 mg escitalopram or placebo daily in a double-blind, parallel group design. On the seventh day of treatment, PRESS data were obtained from a 30×30×20 mm voxel placed in medial frontal cortex. Age and gender-matched healthy controls who received no treatment were also scanned. Levels of NAA were significantly higher in patients treated with escitalopram than in either placebo-treated patients (p<0.01) or healthy controls (p<0.01). Our findings are consistent with the proposition that antidepressant treatment in depressed patients can produce early changes in neuronal integrity.

Original publication

DOI

10.1017/S1461145712000272

Type

Journal article

Journal

Int J Neuropsychopharmacol

Publication Date

11/2012

Volume

15

Pages

1541 - 1546

Keywords

Adolescent, Adult, Antidepressive Agents, Aspartic Acid, Biomarkers, Citalopram, Depressive Disorder, Major, Double-Blind Method, Female, Humans, Magnetic Resonance Spectroscopy, Male, Middle Aged, Neurons, Protons, Time Factors, Treatment Outcome, Young Adult